IL1B and tuberculosis: At month 6 (treatment endpoint), three cytokines were found to be significantly lower in SARS-CoV-2 seropositive TB patients than seronegative: Basic FGF (p=0.0115), IL-1β (p=0.0326) and IL-8 (0.0021) (Figure 5).